Cytomegaloviral disease, unspecified Clinical Trials

7 clinical trials for Cytomegaloviral disease, unspecified across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Characterization of latent HCMV viral load and immunological parameters in adult epilepsy patients receiving pharmacological therapy — RECRUITING
• Suppression of cytomegalovirus latency mechanisms through regulatory effects of specialized neutrophil granulocytes in recurrent sepsis — RECRUITING
• Investigation of the immune response in clinically relevant cytomegalovirus and polyomavirus infections in immunocompromised patients (ICB-Imm) — RECRUITING
• Adoptive immune therapy of chemotherapy-refractory CMV-infection with Streptamer-selected T-cells after allogeneic bone marrow- or peripheral blood stem cell transplantation — RECRUITING
• Risk factors and outcomes of cytomegalovirus (CMV) reactivation in critically ill, non-immunosuppressed patients in the intensive care unit — OTHER
• Clinical validation of an improved T-Track® CMV assay to assess the functionality of CMV protein-reactive cell-mediated immunity (CMI) and its suitability to determine a protective cut-off value for recurrent CMV reactivations in allo-HSCT recipients — OTHER
• Xploit Semantic Support for predictive modeling in Systems Medicine — OTHER

Refine this search